Related Experiment Video
Updated: Aug 21, 2026
Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
[What are the questions concerning small cell lung cancer? How should research be orientated?]
1Service des soins intensifs & Oncologie thoracique, Institut Jules-Bordet, Centre des Tumeurs de l'Université Libre de Bruxelles, 1, rue Héger-Bordet, B-1000 Bruxelles, Belgique. sculier@bordet.be
Abstract:
Spectacular therapeutic progress for small cell lung cancer was obtained some thirty years ago with the introduction of polychemotherapy. Since when, except that which concerns radio-chemotherapy in the limited forms, the development of treatments has been relatively poor. Based on the analysis of published literature, the aim of this review is to discuss the research routes. The problems can be summarised in eleven principle axes: identification of new active drugs, development of new combinations with new chemotherapeutic agents, the place of analogs, the role of thoracic surgery, optimal radio-chemotherapeutic regimens, intensity of chemotherapy, the place of haematological growth factors, the duration of chemotherapy and maintenance treatments, biological treatments, prevention and treatment of cerebral metastases and salvage chemotherapy.
Insights
Small cell lung cancer treatment advanced with polychemotherapy 30 years ago, but progress has since stalled. This review explores research avenues to improve small cell lung cancer therapies.
Area of Science:
- Oncology
- Pulmonology
- Medical Research
Context:
- Small cell lung cancer (SCLC) treatment saw significant progress with polychemotherapy introduction three decades ago.
- Since then, therapeutic advancements for SCLC, excluding limited-stage radio-chemotherapy, have been minimal.
- This highlights a critical need for novel treatment strategies.
Purpose:
- To review and discuss potential research directions for improving small cell lung cancer treatments.
- To identify key challenges and opportunities in SCLC therapy development.
- To synthesize current knowledge and guide future research efforts.
Summary:
- The review analyzes published literature to identify eleven principal research axes for SCLC.
- These axes include discovering new drugs, optimizing drug combinations, exploring analogs, and defining the roles of surgery and radiotherapy.
- Further areas include chemotherapy intensity, duration, maintenance, biological treatments, and managing brain metastases.
Impact:
- Provides a comprehensive overview of research avenues for SCLC treatment.
- Aims to stimulate innovation and accelerate the development of more effective therapies for small cell lung cancer.
- Offers a roadmap for oncologists and researchers in the fight against SCLC.
More Related Videos
11:50Genome-Wide Mapping of Histone Modifications and Transcription Factor Binding Sites in Neuroendocrine Small Cell Lung Cancer Cell Lines Using CUT&RUN
Published on: April 3, 2026
07:59Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023